D
Rhythm Pharmaceuticals, Inc. RYTM
$50.97 $0.731.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -41.11% -39.56% -42.36% -51.70% -1.97%
Total Depreciation and Amortization -11.09% -10.43% -7.23% -4.10% 5.14%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 220.78% 175.49% 243.75% 319.61% 79.08%
Change in Net Operating Assets 119.99% 587.18% 120.24% 98.48% 127.61%
Cash from Operations 16.36% 11.62% 18.96% 10.09% 21.49%
Capital Expenditure -- 102.13% 100.00% 100.00% 83.27%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -757.48% 32.36% -271.69% 122.92% -119.84%
Cash from Investing -750.36% 32.41% -267.89% 122.75% -120.21%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -1.75% -73.42% -54.95% -55.59% -59.43%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -123.57% -116.38% -29.23% -78.11% -76.54%
Cash from Financing 157.16% 73.93% 29.20% -63.08% -65.22%
Foreign Exchange rate Adjustments 101.41% -2,434.00% -1,703.70% -447.67% --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 143.19% 85.94% 1,761.77% -280.25% -198.78%
Weiss Ratings